Results 211 to 220 of about 15,564 (249)

Mutations in the HAstV1/HAstV-8 chimeric virus were found in the FcRn-resistant variants.

Catalina Aguilera-Flores (21743843), María del Pilar Valencia-Morales (21743846), Tomás López (3465071), Joaquín Moreno-Contreras (11999401), Adam Lentz (21743849), Marco A. Espinoza (11999404), Rebecca M. DuBois (145825), Susana López (606291), Carlos F. Arias (8144190)   +8 more
openalex   +1 more source

FcRn-mediated mucosal vaccination with hemagglutinin stalk confers broad protection from influenza virus infections 4198 [PDF]

Weizhong Li, Arunraj Mekhemadhom Rajendrakumar, Zizhen Miao, Bibek Dhakal, Bogdan Mikhailovich Domrachev, Tao Wang, Qiuqi Kan, Wenbin Tuo, Xiaoping Zhu   +8 more
openalex   +1 more source

Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance. [PDF]

Front Immunol
Remaily BC, Young G, Lathrop H, Thomas J, Kim K, Vu TT, Adeluola A, Stanton C, Mulcahy G, Xie Z, Granchie L, Guo Y, Hai M, Wedig J, Schmidt M, Manna M, Mo X, Lowe J, Rafael-Fortney JA, Folefac E, Gregorevic P, Owen DH, Kulp SK, Ganesan LP, Coss CC, Mace TA, Phelps MA.   +26 more
europepmc   +1 more source

The half-life of rFVIIIFc is predominantly extended by FcRn expressed in somatic cells, but not in hematopoietic cells.

, 2015
Arjan van der Flier (729099), Zhan Liu, Tan Siyuan, Chen Kai, Douglas Drager, Tongyao Liu, Patarroyo-White Susannah, Haiyan Jiang, David R. Light (729102)   +8 more
openalex   +2 more sources

Advances in the treatment of autoimmune nodopathy: based on treatment strategies of CIDP. [PDF]

Front Immunol
Pang ZD, Sun H, Wei XJ, Nie CP, Yu XF.
europepmc   +1 more source

Nipocalimab-aahu in generalised myasthenia gravis: A new Fc receptor-targeted option for antibody-positive patients. [PDF]

Ibrain
Hussain JM, Ashfaq A, Shahid A, Mudassir F.   +3 more
europepmc   +1 more source

Analytical Physicochemical and Functional Studies to Compare AryoTrust, a Follow-On Biologics, with the Originator Trastuzumab (Herceptin). [PDF]

Pharmaceutics
Al-Kinani KK, Alkufi HK, Taher SS.
europepmc   +1 more source

Nipocalimab Dose Selection in Generalized Myasthenia Gravis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Valenzuela B, Neyens M, Zhu Y, Ramchandren S, Dosne AG, Leu JH, Faelens R, Ling LE, Pérez-Ruixo JJ.   +8 more
europepmc   +1 more source

Albumin Levels Are Predictive of Cachexia-Induced Time-Dependent Clearance of Therapeutic Antibodies: A Physiologically Based Pharmacokinetic Model of Durvalumab. [PDF]

CPT Pharmacometrics Syst Pharmacol
Proctor JR, Wong H.
europepmc   +1 more source